Toronto Dominion Bank’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
– Sell
-8,300
Closed -$229K – 2025
2025
Q2
$229K Hold
8,300
– – ﹤0.01% 1283
2025
Q1
$235K Buy
+8,300
New +$295K ﹤0.01% 1242

Other funds holding MRNA

Toronto Dominion Bank's MRNA Position: Q2 2026 in Review

Toronto Dominion Bank increased its Moderna (MRNA) stake by 14% in Q2 2026, buying an estimated $461K and bringing the position to 70,922 shares worth $4.97M. The position accounts for 0.01% of the portfolio, ranked #937.

Toronto Dominion Bank first reported a position in MRNA in Q2 2020 and has held it in 25 quarters since. The position peaked at $120M in Q3 2021. 784 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Toronto Dominion Bank held 70,922 shares of Moderna worth $4.97M as of Q2 2026.
  • Toronto Dominion Bank bought 8,910 Moderna shares in Q2 2026, an estimated $461K.
  • Moderna made up 0.01% of Toronto Dominion Bank's portfolio in Q2 2026, its #937 holding.
  • Toronto Dominion Bank first reported a position in Moderna in Q2 2020 and has held it in 25 quarters since.
  • Toronto Dominion Bank's Moderna position peaked at $120M in Q3 2021.
  • 784 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Toronto Dominion Bank's 13F filing for Q2 2026, filed 14 Aug 2026.